3
|
Bertrand A, Aho S, Rousset-Jablonski C, Cessot M, Christophe V, Marec-Bérard P, Ray-Coquard I. Dedicated Program for Adolescent and Young Adults With Cancer: A Better Way to Inform About Sexual and Fertility Issues. JCO Oncol Pract 2021; 17:642. [PMID: 34436935 DOI: 10.1200/op.21.00452] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Amandine Bertrand
- Amandine Bertrand, MD, Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France, RESHAPE U1290, Lyon, France, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Simon Aho, MD, Department of Medical Oncology, Centre Léon Bérard, Lyon, France; Christine Rousset-Jablonski, PhD, RESHAPE U1290, Lyon, France, Department of Surgical Oncology, Centre Léon Bérard, Lyon, France; Marion Cessot, MD, Department of Surgical Oncology, Centre Léon Bérard, Lyon, France; Véronique Christophe, PhD, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Véronique Christophe, PhD, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Perrine Marec-Bérard, MD, Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France; and Isabelle Ray-Coquard, PhD, RESHAPE U1290, Lyon, France, Department of Medical Oncology, Centre Léon Bérard, Lyon, France
| | - Simon Aho
- Amandine Bertrand, MD, Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France, RESHAPE U1290, Lyon, France, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Simon Aho, MD, Department of Medical Oncology, Centre Léon Bérard, Lyon, France; Christine Rousset-Jablonski, PhD, RESHAPE U1290, Lyon, France, Department of Surgical Oncology, Centre Léon Bérard, Lyon, France; Marion Cessot, MD, Department of Surgical Oncology, Centre Léon Bérard, Lyon, France; Véronique Christophe, PhD, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Véronique Christophe, PhD, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Perrine Marec-Bérard, MD, Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France; and Isabelle Ray-Coquard, PhD, RESHAPE U1290, Lyon, France, Department of Medical Oncology, Centre Léon Bérard, Lyon, France
| | - Christine Rousset-Jablonski
- Amandine Bertrand, MD, Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France, RESHAPE U1290, Lyon, France, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Simon Aho, MD, Department of Medical Oncology, Centre Léon Bérard, Lyon, France; Christine Rousset-Jablonski, PhD, RESHAPE U1290, Lyon, France, Department of Surgical Oncology, Centre Léon Bérard, Lyon, France; Marion Cessot, MD, Department of Surgical Oncology, Centre Léon Bérard, Lyon, France; Véronique Christophe, PhD, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Véronique Christophe, PhD, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Perrine Marec-Bérard, MD, Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France; and Isabelle Ray-Coquard, PhD, RESHAPE U1290, Lyon, France, Department of Medical Oncology, Centre Léon Bérard, Lyon, France
| | - Marion Cessot
- Amandine Bertrand, MD, Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France, RESHAPE U1290, Lyon, France, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Simon Aho, MD, Department of Medical Oncology, Centre Léon Bérard, Lyon, France; Christine Rousset-Jablonski, PhD, RESHAPE U1290, Lyon, France, Department of Surgical Oncology, Centre Léon Bérard, Lyon, France; Marion Cessot, MD, Department of Surgical Oncology, Centre Léon Bérard, Lyon, France; Véronique Christophe, PhD, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Véronique Christophe, PhD, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Perrine Marec-Bérard, MD, Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France; and Isabelle Ray-Coquard, PhD, RESHAPE U1290, Lyon, France, Department of Medical Oncology, Centre Léon Bérard, Lyon, France
| | - Véronique Christophe
- Amandine Bertrand, MD, Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France, RESHAPE U1290, Lyon, France, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Simon Aho, MD, Department of Medical Oncology, Centre Léon Bérard, Lyon, France; Christine Rousset-Jablonski, PhD, RESHAPE U1290, Lyon, France, Department of Surgical Oncology, Centre Léon Bérard, Lyon, France; Marion Cessot, MD, Department of Surgical Oncology, Centre Léon Bérard, Lyon, France; Véronique Christophe, PhD, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Véronique Christophe, PhD, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Perrine Marec-Bérard, MD, Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France; and Isabelle Ray-Coquard, PhD, RESHAPE U1290, Lyon, France, Department of Medical Oncology, Centre Léon Bérard, Lyon, France
| | - Perrine Marec-Bérard
- Amandine Bertrand, MD, Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France, RESHAPE U1290, Lyon, France, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Simon Aho, MD, Department of Medical Oncology, Centre Léon Bérard, Lyon, France; Christine Rousset-Jablonski, PhD, RESHAPE U1290, Lyon, France, Department of Surgical Oncology, Centre Léon Bérard, Lyon, France; Marion Cessot, MD, Department of Surgical Oncology, Centre Léon Bérard, Lyon, France; Véronique Christophe, PhD, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Véronique Christophe, PhD, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Perrine Marec-Bérard, MD, Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France; and Isabelle Ray-Coquard, PhD, RESHAPE U1290, Lyon, France, Department of Medical Oncology, Centre Léon Bérard, Lyon, France
| | - Isabelle Ray-Coquard
- Amandine Bertrand, MD, Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France, RESHAPE U1290, Lyon, France, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Simon Aho, MD, Department of Medical Oncology, Centre Léon Bérard, Lyon, France; Christine Rousset-Jablonski, PhD, RESHAPE U1290, Lyon, France, Department of Surgical Oncology, Centre Léon Bérard, Lyon, France; Marion Cessot, MD, Department of Surgical Oncology, Centre Léon Bérard, Lyon, France; Véronique Christophe, PhD, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Véronique Christophe, PhD, Department of Human and Social Sciences, Centre Léon Bérard, Lyon, France; Perrine Marec-Bérard, MD, Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France; and Isabelle Ray-Coquard, PhD, RESHAPE U1290, Lyon, France, Department of Medical Oncology, Centre Léon Bérard, Lyon, France
| |
Collapse
|